Nuvation Bio (NUVB) Short term Debt (2024 - 2026)

Nuvation Bio (NUVB) has reported Short term Debt for 3 consecutive years, with $5.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short term Debt rose 1.85% year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $5.8 million (up 1.85% YoY), while the FY2025 annual figure was $5.7 million, down 8.9% from the prior year.
• Short term Debt rose to $5.8 million in Q1 2026 per NUVB's latest filing, from $5.7 million in the prior quarter.
• Across five years, Short term Debt topped out at $11.6 million in Q2 2024 and bottomed at $5.6 million in Q2 2025.
• Historically, Short term Debt has averaged $6.8 million across 3 years, with a median of $5.8 million in 2025.
• Annual changes were most pronounced in 2025 — Short term Debt plunged 52.01% — and 2026, when it grew 1.85%.
• Nuvation Bio's Short term Debt stood at $6.3 million in 2024, then declined by 8.9% to $5.7 million in 2025, then increased by 1.15% to $5.8 million in 2026.
• Business Quant data shows NUVB's Short term Debt at $5.8 million in Q1 2026, $5.7 million in Q4 2025, and $5.6 million in Q3 2025.